RxDoctor Payments Data

Julie Hodson

Adult Health · Indian River, MINPI 1902150741

Payments from drug & device makers

$2,833in general payments, 2019–2025

Across 82 payments — averaging $34.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • AbbVie$688
  • Novo Nordisk$146
  • Lilly USA, LLC$141
  • Amgen$121
  • Exact Sciences$78
  • plus $207 from 6 others

What the payments were for

  • Food & beverage$2,833100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,833 in reported general payments places this provider in the 85th percentile of 527 adult health providers in Michigan.

See all adult health providers in Michigan

Medicare billing

Part B allowed, 2024
$12,063
Medicare patients
28
Services billed
145

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol94$115,315
EliquisApixaban98$100,407
Trelegy ElliptaFluticasone/Umeclidin/Vilanter137$98,603
JardianceEmpagliflozin83$96,698
TrulicityDulaglutide65$66,593
OzempicSemaglutide63$60,413
MounjaroTirzepatide49$54,270
VraylarCariprazine Hcl24$39,306
TradjentaLinagliptin28$17,425
RybelsusSemaglutide12$15,706
Bydureon BciseExenatide Microspheres11$8,775
MyrbetriqMirabegron13$8,763
SymbicortBudesonide/Formoterol Fumarate29$8,298
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$7,590
Lantus SolostarInsulin Glargine,hum.Rec.Anlog43$5,843

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Symbicort, Breztri Aerosphere$1,451$131,202135 claims
Lilly USA, LLCTrulicity, Mounjaro$141$120,863114 claims
GSKTrelegy Ellipta, Incruse Ellipta$39$102,485149 claims
PfizerEliquis$20$100,40798 claims
Novo NordiskOzempic, Rybelsus$146$76,11975 claims
AbbVieVraylar$688$39,30624 claims
Astellas Pharma US IncMyrbetriq$50$8,76313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 527 adult health providers in Michigan.

Other adult health in Indian River

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →